Pregen
1 known investors
Find your way into Pregen
Sign up to see every warm intro you have to Pregen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pregen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PreGen applies artificial intelligence to gene expression data to develop clinically validated prognostic and predictive molecular tests for cancer patients, starting with prostate cancer. Its tests run on standard PCR equipment with results delivered via a web platform, designed for decentralized deployment in emerging countries, with a focus on Latin America.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Pregen do?
- PreGen applies artificial intelligence to gene expression data to develop clinically validated prognostic and predictive molecular tests for cancer patients, starting with prostate cancer. Its tests run on standard PCR equipment with results delivered via a web platform, designed for decentralized deployment in emerging countries, with a focus on Latin America.
- Who founded Pregen?
- Pregen was founded by Daniel Alonso.
- Who are Pregen's investors?
- Pregen's investors include GRIDX.

